BMAL1 and metabolic syndrome: Disruption of this rhythm in the absence of BMAL1 leads to elevated phosphatidylcholine levels, resulting in altered lipoprotein profiles, an increase in non-HDL cholesterol, and the development of conditions such as fatty liver, dyslipidemia, and metabolic syndrome.